Yuwell Medical Joins CFA Team China as Official Partner: Elevating Health Celebrating Sport
BEIJING, March 3, 2025 /PRNewswire/ -- On March 2, Yuwell Medical and the CFA Team China announced an official partnership at a signing ceremony in Beijing under the theme "Elevating Health Celebrating Sport." Representatives from both organizations...
Sole Pharma - Launches in the Philippines to Meet Rising Demand for High-Quality Supplements
MANILA, Philippines, March 3, 2025 /PRNewswire/ -- In response to the growing demand for high-quality health supplements in the Philippines, Sole Pharma, as one of the leading European pharmaceutical manufacturer, announces its expansion into the...
CARsgen's Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA
SHANGHAI, March 3, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the Center for...
CHARLES LECLERC AND CHIVAS REGAL HIT THE RIGHT NOTE IN NEW GLOBAL PARTNERSHIP
Chivas Regal welcomes Charles Leclerc as Global Brand Ambassador with an exclusive pop-up piano bar ahead of the first Grand Prix of the season, with an appearance from the self-taught pianist. LONDON, March 3, 2025 /PRNewswire/ -- Luxury Scotch...
CJ Olive Young Gangnam Town Introduces Multilingual 'Personal Shopper' Service on a Trial Basis
Customized and multilingual shopping service available at 'Olive Young Gangnam Town' until the end of March Service offered in four languages: Korean, English, Chinese, and Japanese… Specialized staff provide personalized K-beauty shopping...
Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing
SHANGHAI, March 3, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly $100 million Series C financing. This round was...
Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
SAN FRANCISCO and SUZHOU, China, March 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...
Yuewen Global IP Awards Creator Forum: The Rise of China's Global IP Ecosystem
SINGAPORE, March 3, 2025 /PRNewswire/ -- As a pivotal component of the "2024 Yuewen Global IP Awards", the "Yuewen Global IP Awards Creator Forum" was grandly held at Resorts World Sentosa in Singapore on March 1. Representatives from China and...